When: Confirmed daily close above $280 on >15M volume with 3-day follow-through

Then: Revisit toward Hold

Hold core position; tighten stop to below $258 (recent consolidation floor/10 EMA); optionally trim modestly at current levels ($270–$271) if position sizing is a concern; do not commit 25–40% of position to a thesis that requires price to overcome established resistance at $272.67

• Q4 2025 revenue $4.42B, Q1 2026 $4.83B, Q2 2026 $5.46B — three consecutive quarters of sequential growth with Q2 2026 at 13% sequential growth
• Q2 2026 gross margin 61.4%, highest reading in five quarters; diluted EPS nearly doubled off Q4 trough
• Forward P/E 25.4x, PEG 0.95 — forward multiple suggests reasonably priced, not overvalued
• Net PP&E increased from $6.88B in 2022 to $11.91B today (~$5B strategic CapEx), driven by 300mm wafer fabrication transition providing structural cost advantage
• 200 SMA at $242.63 represents the real technical floor; stock trading 11.6% above this level with uptrend intact
• Technical setup is bullish: upper Bollinger Band, positive/widening MACD histogram, RSI at 54 with room to run, bullish follow-through day on above-average volume
• 50 SMA at $272.67 has acted as resistance for weeks; probability of price reaching $272–$278 entry zone is structurally limited
• ATR $8.95 — daily movement of ~$9 means waiting for rallies is unnecessary given position is already exposed
• Stop recommendation: below $258 (recent consolidation floor/10 EMA)
• Trim recommendation: at current levels $270–$271 rather than waiting for $272–$278 zone
• 48% one-year total shareholder return; institutional/dividend-focused shareholder base is stable, not concerning
• No Fed cuts (96% probability in 2026) creates soft landing trajectory, which is actually bullish for cyclical end demand
• Disciplined capital allocation means reallocating from buybacks to higher IRR strategic CapEx; compares to Apple 2005 or Amazon 2010 reinvestment phases

→ vs aggressive: Earnings revisions 'rolling over' thesis relies on single Zacks article caveat in a price-action piece, not actual sequential data showing three consecutive quarters of revenue growth and margin expansion to 61.4%

→ vs aggressive: Capital allocation 'regime change' misreads strategic CapEx deployment (300mm fabs) as defensive capitulation; management is choosing higher internal rate of return over buybacks, not retreating

→ vs aggressive: 41x trailing P/E is misleading for cyclical; forward P/E of 25.4x and PEG of 0.95 prove the market is pricing the recovery, making this a directional bet on recovery failure, not a valuation call

→ vs aggressive: 'Zero Reddit posts' thesis is weak; absence of retail interest signals institutional ownership stability, not bearishness, and has supported 48% one-year return

→ vs neutral: Trade plan sells into rallies at $272–$278 with stop at $280, but stop sits above entry zone and 50 SMA at $272.67 has acted as resistance; plan depends on price behavior the chart structurally argues against

→ vs neutral: Waiting for $272–$278 to trim when stock trades at $270 leaves 2.6% of additional drawdown on the table for no analytical reason given ATR of $8.95 and exposed position thesis

Trim 15-20% at current levels (270-272 zone), tighten stop to 258 daily close on remaining position, reassess after Q3 earnings mid-October

• Three consecutive quarters of sequential revenue growth with most recent quarter up 13%, gross margin at 61.4% (highest in five quarters), EPS nearly doubled off Q4 trough
• Forward P/E of 25.4x with PEG of 0.95 indicates estimates are not rolling over meaningfully
• 300mm fab transition represents ~$5 billion strategic capex (Net PP&E from $6.88B to $11.91B) with compounding structural cost advantage
• 50 SMA at 272.67 acting as resistance with repeated rejections; MACD still negative despite histogram improvement
• 90-day momentum of minus 19.26% signals something broke in August that the chart has not confirmed healed
• Entry zone of 272-278 requires price to overcome a ceiling the chart is actively rejecting
• Stop at 280 is structurally unlikely to be triggered given resistance at 272.67, creating false sense of risk control
• Q3 earnings in mid-October is the binary catalyst the tape is hedging around
• Capital allocation regime change (61% debt increase, 59% buyback cut) is strategic investment, not capitulation

→ vs aggressive: The 'earnings revisions rolling over' thesis is based on one Zacks article's editorial framing, not primary data; actual reported earnings show three consecutive quarters of sequential revenue growth with margins expanding, inconsistent with a company whose estimates are rolling over

→ vs aggressive: The 'regime change from offense to defense' framing misreads strategic capex as defensive; the 300mm transition is a higher-return use of capital than buybacks, exactly the disciplined allocation long-term shareholders should want

→ vs aggressive: Peer weakness and macro backdrop are important inputs but do not individually or collectively override structural franchise quality; 'things could go wrong' is not the same as 'things will go wrong'

→ vs conservative: 90-day momentum of minus 19.26% cannot be dismissed as irrelevant because YTD is plus 46.84%; the question is what is happening now and likely over the next 1-3 months, not what happened year-to-date

→ vs conservative: Peer weakness (ON Semi down 50%, AMAT down 21%) cannot be waved away; AMAT is a leading indicator for fab utilization and ON Semi is the closest analog peer

→ vs conservative: Trade construction is too vague to be useful; 'hold core, tighten stop, trim modestly' is a posture, not a plan; lacks specific price levels, sizing, and trigger conditions